Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results83% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (11)

Trial Status

Completed5
Recruiting3
Active Not Recruiting3
Unknown3
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT05291247Completed

Shockwave IVL + DES

NCT04971772Active Not Recruiting

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

NCT07338890Not Yet RecruitingPrimary

Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

NCT05132361Not ApplicableActive Not Recruiting

SELUTION4SFA Trial

NCT04434586Not ApplicableRecruitingPrimary

Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions

NCT06410313Not ApplicableRecruitingPrimary

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

NCT06416644Not ApplicableActive Not Recruiting

The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

NCT06734221Not ApplicableRecruiting

STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

NCT05451485Completed

VFI in Healthy Vessels

NCT05079906Not ApplicableWithdrawn

Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® Catheter

NCT04461496Not ApplicableUnknownPrimary

Full Metall Jacket Multilevel Segment

NCT04175197Unknown

LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries

NCT00908947Not ApplicableTerminatedPrimary

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

NCT03121430Not ApplicableUnknown

Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion

NCT01602159Not ApplicableCompletedPrimary

Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)

NCT01336101Not ApplicableCompleted

Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent

NCT01327950CompletedPrimary

Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions

Showing all 17 trials

Research Network

Activity Timeline